PR91362

LAUSANNE, Switzerland, Aug. 31, 2021 /PRNewswire=KYODO JBN/--

Alithea Genomics, a rapidly growing player in the transcriptomics field, has

announced today the launch of its first MERCURIUS BRB-seq kits, which enable

high-throughput and cost-efficient RNA-seq library preparation from a wide

range of RNA samples.

BRB-seq is Alithea's flagship technology and is based on early sample barcoding

and pooling. With BRB-seq, right after the initial reverse transcription

reaction, hundreds of RNA samples can be processed in one single tube. This

translates into a significant reduction of reagents and manual effort involved

in the overall workflow.

The MERCURIUS BRB-seq kits provide an optimized set of barcodes, which ensure

uniform and reproducible data generation from a large number of samples.

Moreover, the newly launched BRB-seq kits are also optimized for RNA samples

from various tissue types. In addition to standard purified RNA, the BRB-seq

kits are also compatible with cell lysates (i.e. no need for RNA extraction)

and for blood RNA samples (i.e. globin depletion is integrated in the BRB-seq

workflow).

"We are particularly proud of our first kits, especially after a successful

beta-testing period with early adopters" said Daniel Alpern, CTO at Alithea

Genomics. "BRB-seq has already proved itself an empowering solution for several

users and now, through our kits, we want to make easy and convenient for anyone

to adopt this new technology".

More information can be requested at info@alitheagenomics.com or visiting:

https://www.alitheagenomics.com/contact

About Alithea Genomics

Founded in 2020, Alithea Genomics SA is a rapidly growing provider of

high-throughput RNA-seq services, kits and bioinformatic solutions. Alithea's

products are ideal for large-scale transcriptomics studies such as biomarker

discovery, antibody development and drug screening. In addition to human

health, BRB-seq can easily be applied to model organisms, plants and in-vitro

models.

Alithea Genomics is a privately held company based in Lausanne (Switzerland)

and is currently shipping its kits directly and worldwide. For more information

about Alithea Genomics, visit: https://www.alitheagenomics.com/

Contact: Riccardo Dainese

         CEO

         riccardo.dainese@alitheagenomics.com

         +41-788-30-31-39

Logo - https://mma.prnewswire.com/media/1603362/Alithea_Genomics_Logo.jpg

SOURCE:  Alithea Genomics